FDA panel OKs Medtronic's Amplify - DOTmed.com TopNews United Kingdom (blog)FDA panel OKs Medtronic's AmplifyDOTmed.comFDA 39;s Orthopaedic and Rehabilitation Devices panel looked at data regarding the product from a trial, and found the product safe and effective for fusions ...FDA orthopedic panel gives nod to Medtronic rhMBP-2 AMPLIFY for posterolateral ...Ortho SuperSiteFDA Panel Split on Medtronic Spine DeviceMedPage TodayFDA Panel Splits On Benefits,Risks Of Medtronic Spine DeviceWall Street JournalBizjournals.com -TMC Netall 136 news articles » Read More...
Zimmer 2Q Down 21% On Higher Charges; Masking Sales Growth - Wall Street Journal RTT NewsZimmer 2Q Down 21% On Higher Charges; Masking Sales GrowthWall Street JournalZimmer Holdings Inc.'s (ZMH) second-quarter profit slid 21% on higher charges and lower margins, although the maker of orthopaedic products such as knee ...Zimmer Reports Second Quarter 2010 Financial ResultsAmerican ChronicleZimmer Reports Second Quarter 2010 Financial ResultsCentre Daily Timesall 38 news articles » Read More...
FDA Concerned with Cancer Rates for New Spine Device - MedPage Today FDA Concerned with Cancer Rates for New Spine DeviceMedPage TodayAn FDA's Orthopaedic and Rehabilitation Devices advisory panel will meet Tuesday to discuss the safety and efficacy of the device -- called Amplify -- as ...FDA looks at Medtronic's Amplify's potential cancer risksDOTmed.comall 8 news articles » Read More...